TScan is a fully integrated clinical-stage biotech company focused on developing a robust pipeline of TCR-T therapies for the treatment of patients with cancer
Join @TScan_Tx ($TCRX) on Dec 11 at 8 am ET for a virtual KOL event featuring @DrMonzrAlMalki who will review the initial results from the Phase 1 trial of TSC-100 and TSC-101 presented at #ASH2023 and discuss the potential for TCR-T in cancer. Register: lifescievents.com/event/tsca…
We're pleased to partner with @TScan_Tx on this bespoke $60M financing to support the continued advancement of their TCR-T pipeline. TScan drew $30M upon closing of the loan, providing the ability for both parties to convert principal into equity: https://teapaw.org/t.co/Bp23BPLXBU